Immune Reconstitution Inflammatory Syndrome: Clinical Trials

14 trials for Immune Reconstitution Inflammatory Syndrome, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed, 3 recruiting, 1 terminated, 1 unknown. 4 Not applicable, 2 Phase 2, 2 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable4Completed 3, Unknown 1
Phase 22Completed 1, Withdrawn 1
Phase 32Completed 1, Withdrawn 1
Phase 41Terminated 1

Follow Immune Reconstitution Inflammatory Syndrome: new trials by email Literature Review of Immune Reconstitution Inflammatory Syndrome trials Research Report on Immune Reconstitution Inflammatory Syndrome

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Same-day Versus Rapid ART Initiation in HIV-positive Individuals Presenting With Symptoms of Tuberculosis
ART first- Therapeutic use trial, TB results first- Therapeutic use trial - Human Immunodeficiency Virus (HIV) Infection
Not applicableCompletedUniversity Hospital, Basel, Switzerland6102022-10-192025-04-04
Paradoxical Tuberculosis Reactions in Patients Without HIV Infection
Tuberculosis
RecruitingNational Institute of Allergy and Infectious Diseases (NIAID)1402019-12-202026-10-19
Impact of Valganciclovir on Severe IRIS-Kaposi Sarcoma Mortality: an Open-label, Parallel, Randomized Controlled-trial.
Valganciclovir, Antiretroviral Combinations - Kaposi Sarcoma, Human Immunodeficiency Virus
Phase 2CompletedNational Institute of Cancerología402015-10-012022-01-27
PET Imaging and Lymph Node Assessment of IRIS in People With AIDS
Immune Reconstitution Inflammatory Syndrome
RecruitingNational Institute of Allergy and Infectious Diseases (NIAID)3002014-05-302026-10-08
Paradoxical Tuberculosis Immune Reconstitution Inflammatory Syndrome (TB-IRIS) Treatment Trial
Dexamethasone, Atorvastatin, Naproxen - Immune Reconstitution Inflammatory Syndrome, Immune Reconstitution Syndrome
Phase 2 / Phase 3WithdrawnUniversity of Minnesota2014-01-012013-11-25
Hepatosplenic CANdidiasis : PETscan and Immune Response Analysis
18F-FDG PET Scan - Invasive Fungal Disease, Chronic Disseminated Candidiasis
Not applicableCompletedAssistance Publique - Hôpitaux de Paris1002013-11-192025-09-08
Preventing TB-IRIS in High-risk Patients: a Randomized Placebo-controlled Trial of Prednisone
Prednisone, Placebo - Immune Reconstitution Inflammatory Syndrome, HIV
Phase 3CompletedUniversity of Cape Town2402013-08-302018-01-19
Pediatric Urgent Start of Highly Active Antiretroviral Treatment (HAART)
Urgent ART, Early ART - Human Immunodeficiency Virus, Immune Reconstitution Inflammatory Syndrome
Not applicableCompletedUniversity of Washington1832013-03-012018-05-14
Natural History Study of Progressive Multifocal Leukoencephalopathy (PML)
Progressive Multifocal Leukoencephalopathy
RecruitingNational Institute of Neurological Disorders and Stroke (NINDS)7002012-11-082026-08-31
Prediction and Pathogenesis of the Immune Reconstitution Inflammatory Syndrome
Immune Reconstitution Inflammatory Syndrome, Opportunistic Infections
CompletedAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1072012-01-012015-01-14
Corticosteroids for Immune Reconstitution Inflammatory Syndrome (IRIS)
Methylprednisolone, Prednisolone - Immune Reconstitution Inflammatory Syndrome, Leukoencephalopathy, Progressive Multifocal
Phase 4TerminatedBiogen32010-09-012014-09-05
Maraviroc (CCR5) Antagonism to Decrease the Incidence of the Immune Reconstitution Inflammatory Syndrome in HIV-Infected Patients
maraviroc, Placebo - Immune Reconstitution Inflammatory Syndrome, HIV
Not applicableUnknownInstituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran2762009-12-012012-11-27
Do CCR5 Antagonists Improve the Overall Survival of Patients With AIDS-related Progressive Multifocal Leucoencephalopathy?
Measure of overall survival - AIDS, Progressive Multifocal Leucoencephalopathy (PML)
CompletedFondation Ophtalmologique Adolphe de Rothschild342008-01-012019-05-31
Immune Reconstitution Syndrome in HIV-Infected Patients Taking Antiretroviral Therapy
Immune Reconstitution Inflammatory Syndrome
CompletedNational Institute of Allergy and Infectious Diseases (NIAID)5252006-02-012019-10-07

Narrower conditions

Acquired Immunodeficiency Syndrome (6)  ·  Tuberculosis (4)  ·  Leukoencephalopathy, Progressive Multifocal (3)  ·  Opportunistic Infections (2)  ·  Encephalitis (1)  ·  Genetic Predisposition to Disease (1)  ·  HIV Infections (1)  ·  Hematologic Neoplasms (1)  ·  Infections (1)  ·  Invasive Fungal Infections (1)  ·  Multiple Sclerosis (1)  ·  Mycobacterium Infections (1)  ·  Neutropenia (1)  ·  Sarcoma, Kaposi (1)

Broader conditions

Immune System Diseases (14)  ·  Infections (12)  ·  Virus Diseases (8)  ·  Blood-Borne Infections (7)  ·  Communicable Diseases (7)  ·  Genital Diseases (7)  ·  Immunologic Deficiency Syndromes (7)  ·  Lentivirus Infections (7)  ·  RNA Virus Infections (7)  ·  Retroviridae Infections (7)  ·  Sexually Transmitted Diseases (7)  ·  Sexually Transmitted Diseases, Viral (7)  ·  Slow Virus Diseases (7)  ·  Urogenital Diseases (7)  ·  Bacterial Infections and Mycoses (6)

Interventions

Atorvastatin (1)  ·  Calcium Dobesilate (1)  ·  Dexamethasone (1)  ·  Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination (1)  ·  Maraviroc (1)  ·  Methylprednisolone (1)  ·  Methylprednisolone Hemisuccinate (1)  ·  Naproxen (1)  ·  Prednisolone (1)  ·  Prednisone (1)  ·  Valganciclovir (1)  ·  efavirenz (1)

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID) (3)  ·  Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Biogen (1)  ·  Fondation Ophtalmologique Adolphe de Rothschild (1)  ·  Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran (1)  ·  National Institute of Cancerología (1)  ·  National Institute of Neurological Disorders and Stroke (NINDS) (1)  ·  University Hospital, Basel, Switzerland (1)  ·  University of Cape Town (1)  ·  University of Minnesota (1)  ·  University of Washington (1)

Countries

United States (6)  ·  Mexico (3)  ·  South Africa (2)  ·  Thailand (2)  ·  France (1)  ·  Gabon (1)  ·  Germany (1)  ·  Kenya (1)  ·  Lesotho (1)  ·  Malawi (1)

Top investigators

Irini Sereti, M.D. (2)  ·  David R Boulware, MD, MPH (1)  ·  Grace John Stewart, MD, PhD (1)  ·  Graeme Meintjes, MD MPH PhD (1)  ·  Ian Sanne, MBBCH, FCP (1)  ·  Irene CM Cortese, M.D. (1)  ·  Irini Sereti, M.D., MHS (1)  ·  Juan G Sierra Madero, MD (1)  ·  Livio Azzoni, MD, PhD (1)  ·  Luis J Montaner, M.Sc. (1)  ·  MP Grobusch, MD, MSc (1)  ·  Maura M Manion, M.D. (1)  ·  Michael M. Lederman, MD (1)  ·  Niklaus Labhardt, Prof. Dr. DTM&H, MIH (1)

Results publications

PMID 37040388, PMID 38564303, PMID 20660788, PMID 22219223, PMID 26366430, PMID 27308805, PMID 28609404, PMID 29150377, PMID 29324985, PMID 30215671, PMID 30428290, PMID 31095004, PMID 31879764, PMID 32016127, PMID 32493198, PMID 32761193, PMID 33336253, PMID 35812431, PMID 36606049, PMID 38016160, PMID 38330045, PMID 38941593, PMID 41692011

NIH funding

R01HD023412 (1)